Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center Retrospective Study to Develop a Nomogram for Predicting Recurrence in HR+/HER2- Early Breast Cancer Using Real-World Data

NCT07484763 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT07484763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07484763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center Retrospective Study to Develop a Nomogram for Predicting Recurrence in HR+/HER2- Early Breast Cancer Using Real-World Data
Lead sponsor
Shengjing Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
April 1, 2027
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, hr+/her2- early-stage